Skip Navigation LinksHome > July 2013 - Volume 21 - Issue 4 > Expression of Squamous Cell Carcinoma Markers and Adenocarci...
Applied Immunohistochemistry & Molecular Morphology:
doi: 10.1097/PAI.0b013e31826fd4f3
Research Articles

Expression of Squamous Cell Carcinoma Markers and Adenocarcinoma Markers in Primary Pulmonary Neuroendocrine Carcinomas

Masai, Kyohei MD*,†; Tsuta, Koji MD, PhD*; Kawago, Mitsumasa MD*,†; Tatsumori, Takahiro MD*; Kinno, Tomoaki MD*; Taniyama, Tomoko MD*; Yoshida, Akihiko MD, PhD*; Asamura, Hisao MD, PhD; Tsuda, Hitoshi MD, PhD*

Collapse Box


Recent clinical trials have revealed that accurate histologic typing of non–small cell lung cancer is essential. Until now, squamous cell carcinoma (SQC) and adenocarcinoma (ADC) markers have not been thoroughly analyzed for pulmonary neuroendocrine carcinomas (NECs). We analyzed the expression of 8 markers [p63, cytokeratin (CK) 5/6, SOX2, CK7, desmocollin 3, thyroid transcription factor-1 (8G7G3/1 and SPT24), and napsin A] in 224 NECs. SOX2 (76.2%) had the greatest expression for NECs. CK5/6 (1.4%), desmocollin 3 (0.5%), and napsin A (0%) were expressed less or not at all in NECs. Although our investigated markers have been reported useful for differentiating between SQC and ADC, some of them were also present in a portion of pulmonary NECs. In our study, CK5/6 and desmocollin 3 were highly specific markers for SQC, and napsin A was highly specific for ADC. These markers are recommended for diagnosis of poorly differentiated non–small cell lung cancer.

© 2013 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.